
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4176570
[patent_doc_number] => 06037140
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-14
[patent_title] => 'Selective media for the culture and isolation of gram bacteria, antibiotic composition'
[patent_app_type] => 1
[patent_app_number] => 8/729604
[patent_app_country] => US
[patent_app_date] => 1996-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2785
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/037/06037140.pdf
[firstpage_image] =>[orig_patent_app_number] => 729604
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/729604 | Selective media for the culture and isolation of gram bacteria, antibiotic composition | Oct 10, 1996 | Issued |
Array
(
[id] => 3876740
[patent_doc_number] => 05747466
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => '3-deoxy-3-descladinose derivatives of erythromycins A and B'
[patent_app_type] => 1
[patent_app_number] => 8/729269
[patent_app_country] => US
[patent_app_date] => 1996-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14405
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747466.pdf
[firstpage_image] =>[orig_patent_app_number] => 729269
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/729269 | 3-deoxy-3-descladinose derivatives of erythromycins A and B | Oct 9, 1996 | Issued |
Array
(
[id] => 4285634
[patent_doc_number] => 06268182
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Method and producing phosphorylated saccharides'
[patent_app_type] => 1
[patent_app_number] => 8/719864
[patent_app_country] => US
[patent_app_date] => 1996-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 31
[patent_no_of_words] => 18736
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268182.pdf
[firstpage_image] =>[orig_patent_app_number] => 719864
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/719864 | Method and producing phosphorylated saccharides | Sep 24, 1996 | Issued |
Array
(
[id] => 3992315
[patent_doc_number] => 05891862
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Polyvalent polymers for the treatment of rotavirus infection'
[patent_app_type] => 1
[patent_app_number] => 8/717265
[patent_app_country] => US
[patent_app_date] => 1996-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12259
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891862.pdf
[firstpage_image] =>[orig_patent_app_number] => 717265
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/717265 | Polyvalent polymers for the treatment of rotavirus infection | Sep 19, 1996 | Issued |
Array
(
[id] => 3827816
[patent_doc_number] => 05760005
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Stabilized caloric nutrient solution and a multicompartmental system or multiple recipient for human parenteral nourishing'
[patent_app_type] => 1
[patent_app_number] => 8/713021
[patent_app_country] => US
[patent_app_date] => 1996-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2001
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/760/05760005.pdf
[firstpage_image] =>[orig_patent_app_number] => 713021
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/713021 | Stabilized caloric nutrient solution and a multicompartmental system or multiple recipient for human parenteral nourishing | Sep 11, 1996 | Issued |
Array
(
[id] => 3814821
[patent_doc_number] => 05789386
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Fluorine-containing anthracycline derivatives having hydroxyl groups(s) mono- or di-o-aminoalkanoylated in the sugar moiety thereof'
[patent_app_type] => 1
[patent_app_number] => 8/709297
[patent_app_country] => US
[patent_app_date] => 1996-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31394
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/789/05789386.pdf
[firstpage_image] =>[orig_patent_app_number] => 709297
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/709297 | Fluorine-containing anthracycline derivatives having hydroxyl groups(s) mono- or di-o-aminoalkanoylated in the sugar moiety thereof | Sep 8, 1996 | Issued |
Array
(
[id] => 4035993
[patent_doc_number] => 05942611
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-24
[patent_title] => 'Process for natamycin recovery'
[patent_app_type] => 1
[patent_app_number] => 8/696841
[patent_app_country] => US
[patent_app_date] => 1996-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1863
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/942/05942611.pdf
[firstpage_image] =>[orig_patent_app_number] => 696841
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/696841 | Process for natamycin recovery | Aug 27, 1996 | Issued |
Array
(
[id] => 3869168
[patent_doc_number] => 05837695
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Fluorescent chlamydia antigen substrate'
[patent_app_type] => 1
[patent_app_number] => 8/701340
[patent_app_country] => US
[patent_app_date] => 1996-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3348
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837695.pdf
[firstpage_image] =>[orig_patent_app_number] => 701340
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/701340 | Fluorescent chlamydia antigen substrate | Aug 21, 1996 | Issued |
Array
(
[id] => 3949777
[patent_doc_number] => 05955450
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Peritoneal dialysis solutions and methods usable to minimize the injury and adverse physiological effects caused by peritonitis'
[patent_app_type] => 1
[patent_app_number] => 8/698599
[patent_app_country] => US
[patent_app_date] => 1996-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3649
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955450.pdf
[firstpage_image] =>[orig_patent_app_number] => 698599
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/698599 | Peritoneal dialysis solutions and methods usable to minimize the injury and adverse physiological effects caused by peritonitis | Aug 15, 1996 | Issued |
Array
(
[id] => 3933824
[patent_doc_number] => 05929052
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Energy formulation'
[patent_app_type] => 1
[patent_app_number] => 8/693136
[patent_app_country] => US
[patent_app_date] => 1996-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2183
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/929/05929052.pdf
[firstpage_image] =>[orig_patent_app_number] => 693136
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/693136 | Energy formulation | Aug 12, 1996 | Issued |
Array
(
[id] => 4002800
[patent_doc_number] => 05858986
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Crystal form I of clarithromycin'
[patent_app_type] => 1
[patent_app_number] => 8/681723
[patent_app_country] => US
[patent_app_date] => 1996-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5525
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858986.pdf
[firstpage_image] =>[orig_patent_app_number] => 681723
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/681723 | Crystal form I of clarithromycin | Jul 28, 1996 | Issued |
| 08/681421 | COMPOSITIONS FOR TREATING ESCHERICHIA COLI URINARY TRACT INFECTIONS | Jul 22, 1996 | Abandoned |
Array
(
[id] => 3923880
[patent_doc_number] => 05914320
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-22
[patent_title] => 'Co-milled mixtures comprising polyol and method of making'
[patent_app_type] => 1
[patent_app_number] => 8/684118
[patent_app_country] => US
[patent_app_date] => 1996-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4826
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/914/05914320.pdf
[firstpage_image] =>[orig_patent_app_number] => 684118
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/684118 | Co-milled mixtures comprising polyol and method of making | Jul 18, 1996 | Issued |
Array
(
[id] => 3850781
[patent_doc_number] => 05767096
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Bromotiacumicin compounds'
[patent_app_type] => 1
[patent_app_number] => 8/678906
[patent_app_country] => US
[patent_app_date] => 1996-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7151
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767096.pdf
[firstpage_image] =>[orig_patent_app_number] => 678906
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/678906 | Bromotiacumicin compounds | Jul 11, 1996 | Issued |
Array
(
[id] => 4063900
[patent_doc_number] => 05866533
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Polyhydroxycarboxylic acid composition derived from maltodextrins by oxidation with an oxygen containing oxidant'
[patent_app_type] => 1
[patent_app_number] => 8/678711
[patent_app_country] => US
[patent_app_date] => 1996-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 3201
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866533.pdf
[firstpage_image] =>[orig_patent_app_number] => 678711
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/678711 | Polyhydroxycarboxylic acid composition derived from maltodextrins by oxidation with an oxygen containing oxidant | Jul 10, 1996 | Issued |
Array
(
[id] => 3775093
[patent_doc_number] => 05817633
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'Treatment of cholera'
[patent_app_type] => 1
[patent_app_number] => 8/678059
[patent_app_country] => US
[patent_app_date] => 1996-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 10426
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817633.pdf
[firstpage_image] =>[orig_patent_app_number] => 678059
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/678059 | Treatment of cholera | Jul 8, 1996 | Issued |
Array
(
[id] => 3817513
[patent_doc_number] => 05789569
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Isothiocyanated cyclodextrin derivative'
[patent_app_type] => 1
[patent_app_number] => 8/675961
[patent_app_country] => US
[patent_app_date] => 1996-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 33
[patent_no_of_words] => 9611
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/789/05789569.pdf
[firstpage_image] =>[orig_patent_app_number] => 675961
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/675961 | Isothiocyanated cyclodextrin derivative | Jul 4, 1996 | Issued |
Array
(
[id] => 3886429
[patent_doc_number] => 05723447
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Water miscible erythromycin solutions'
[patent_app_type] => 1
[patent_app_number] => 8/675380
[patent_app_country] => US
[patent_app_date] => 1996-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1079
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723447.pdf
[firstpage_image] =>[orig_patent_app_number] => 675380
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/675380 | Water miscible erythromycin solutions | Jul 1, 1996 | Issued |
Array
(
[id] => 3832941
[patent_doc_number] => 05712253
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-27
[patent_title] => 'Macrocyclic 13-membered ring derivatives of erythromycins A and B'
[patent_app_type] => 1
[patent_app_number] => 8/668050
[patent_app_country] => US
[patent_app_date] => 1996-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7315
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/712/05712253.pdf
[firstpage_image] =>[orig_patent_app_number] => 668050
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/668050 | Macrocyclic 13-membered ring derivatives of erythromycins A and B | Jun 17, 1996 | Issued |
Array
(
[id] => 3743664
[patent_doc_number] => 05786460
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-28
[patent_title] => 'Antifungal antibiotic cepacidine A'
[patent_app_type] => 1
[patent_app_number] => 8/632458
[patent_app_country] => US
[patent_app_date] => 1996-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3265
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/786/05786460.pdf
[firstpage_image] =>[orig_patent_app_number] => 632458
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/632458 | Antifungal antibiotic cepacidine A | Jun 17, 1996 | Issued |